Ultrasound Guided Median Nerve Hydrodissection Using Dextrose

Not Applicable

Completed

• Conditions: Carpal Tunnel Syndrome

• Registration Number: NCT05725460
• Lead Sponsor: Iraqi Board of medical specialties

Brief Summary

to compare the efficacy of dextrose 5% with steroid hydrodissection in patients with carpal tunnel syndrome

Detailed Description

in some cases there is prohibition to use steroid with example the patient rejection to use steroid the maneuver planned median nerve hydrodissection using ultrasound and 10 mld of dextrose 5%, unleash the median nerve for the surrounding structure and short follow up planned to be 2 weeks

Study Timeline

• Study First Submitted: 2023-01-23
• Study Start: 2023-02-01
• Study First Submitted QC: 2023-02-02
• Study First Posted: 2023-02-13
• Status Verified: 2023-05
• Primary Completion: 2023-08-23
• Study Completion: 2023-09-13
• Last Update Submitted: 2023-09-27
• Last Update Posted: 2023-09-29

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

severe carpal tunnel syndrome failed medical management -

Exclusion Criteria

previous failed surgery previous failed injection previous failed trial of hydrodissection cervical or brachial nerve entrapment wrist osteoarthritis or rheumatoid pregnant diabetes mellitus

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
pain relief in 2 weeks follow up	6 months	difference in sensory and functional symptoms post median nerve hydrodissection using dextrose and compare this effect with steroid population arm using Boston questionnaire

Trial Locations

Locations (1)

Baghdad Medical City; 🇮🇶 Baghdad, Iraq